Fidelity Investments
NEO icon

Fidelity Investments’s NeoGenomics NEO Stock Holding History

Fidelity Investments’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Buy
226,313
+55,826
+33% +$587K ﹤0.01% 2694
2025
Q4 		$2M Buy
170,487
+133,359
+359% +$1.44M ﹤0.01% 2619
2025
Q3 		$287K Sell
37,128
-117,243
-76% -$821K ﹤0.01% 3229
2025
Q2 		$1.13M Buy
154,371
+146,106
+1,768% +$1.18M ﹤0.01% 2678
2025
Q1 		$78.4K Sell
8,265
-17,548
-68% -$219K ﹤0.01% 3664
2024
Q4 		$425K Buy
25,813
+12,558
+95% +$195K ﹤0.01% 2991
2024
Q3 		$196K Buy
13,255
+931
+8% +$14.6K ﹤0.01% 3207
2024
Q2 		$171K Sell
12,324
-2,892
-19% -$41K ﹤0.01% 3083
2024
Q1 		$239K Buy
15,216
+663
+5% +$10.2K ﹤0.01% 2975
2023
Q4 		$235K Buy
14,553
+6,441
+79% +$105K ﹤0.01% 2913
2023
Q3 		$99.8K Sell
8,112
-459
-5% -$6.83K ﹤0.01% 3094
2023
Q2 		$138K Sell
8,571
-728
-8% -$12K ﹤0.01% 3056
2023
Q1 		$162K Buy
9,299
+1,403
+18% +$20K ﹤0.01% 3055
2022
Q4 		$73K Sell
7,896
-6,345
-45% -$59.1K ﹤0.01% 3319
2022
Q3 		$122K Buy
14,241
+3,520
+33% +$35K ﹤0.01% 3202
2022
Q2 		$88K Buy
10,721
+8,497
+382% +$81.1K ﹤0.01% 3376
2022
Q1 		$27K Buy
2,224
+337
+18% +$7.09K ﹤0.01% 3900
2021
Q4 		$65K Sell
1,887
-178
-9% -$6.97K ﹤0.01% 3174
2021
Q3 		$99K Buy
2,065
+973
+89% +$45K ﹤0.01% 3079
2021
Q2 		$49K Buy
1,092
+42
+4% +$1.86K ﹤0.01% 3168
2021
Q1 		$51K Sell
1,050
-362
-26% -$18.8K ﹤0.01% 3041
2020
Q4 		$76K Sell
1,412
-931
-40% -$42.1K ﹤0.01% 2930
2020
Q3 		$86K Buy
2,343
+1,114
+91% +$41.4K ﹤0.01% 2815
2020
Q2 		$38K Buy
1,229
+262
+27% +$7.26K ﹤0.01% 2851
2020
Q1 		$27K Sell
967
-37
-4% -$1.11K ﹤0.01% 2891
2019
Q4 		$30K Sell
1,004
-124,182
-99% -$2.96M ﹤0.01% 3016
2019
Q3 		$2.39M Buy
125,186
+123,837
+9,180% +$2.9M ﹤0.01% 2228
2019
Q2 		$29K Buy
1,349
+1,302
+2,770% +$28.6K ﹤0.01% 2988
2019
Q1 		$1K Buy
+47
New +$817 ﹤0.01% 3495

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fidelity Investments's NEO Position: Q1 2026 in Review

Fidelity Investments increased its NeoGenomics (NEO) stake by 33% in Q1 2026, buying an estimated $587K and bringing the position to 226,313 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2694.

Fidelity Investments first reported a position in NEO in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.39M in Q3 2019. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Fidelity Investments held 226,313 shares of NeoGenomics worth $1.68M as of Q1 2026.
  • Fidelity Investments bought 55,826 NeoGenomics shares in Q1 2026, an estimated $587K.
  • NeoGenomics made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #2694 holding.
  • Fidelity Investments first reported a position in NeoGenomics in Q1 2019 and has held it in 29 quarters since.
  • Fidelity Investments's NeoGenomics position peaked at $2.39M in Q3 2019.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.